Sign Up to like & get
recommendations!
0
Published in 2018 at "Nano letters"
DOI: 10.1021/acs.nanolett.8b03015
Abstract: Bortezomib (BTZ) is a first-in-class boronate proteasome inhibitor used for cancer therapy, but its therapeutic efficacy is usually inhibited by dietary polyphenols due to boronate-catechol complexation. Benefiting from such dynamic covalent chemistry, herein we describe…
read more here.
Keywords:
foe friend;
supramolecular nanomedicines;
friend supramolecular;
consisting natural ... See more keywords